Skip to main content
. 2017 Jul;18(7):929–945. doi: 10.1016/S1470-2045(17)30404-7

Figure 4.

Figure 4

Mean change in scores on the EORTC QLQ-C30 global health status quality-of-life scale from baseline. by treatment

EORTC=European Organisation for Research and Treatment of Cancer. E=standard epirubicin. aE=accelerated epirubicin. CMF=cyclophosphamide, methotrexate, and fluorouracil. X=capecitabine. *At baseline and all timepoints of interest. †p value from ANCOVA analysis of E versus aE and for CMF versus X, adjusted for baseline subscale score.